Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Phase III randomized double-blind placebo-controlled trial of metformin for cognitive recovery and white matter growth in paediatric medulloblastoma patients
Protocol ID
MetMED
Disease (Sub Disease)
Medulloblastoma
Diagnosis Stage
Previously treated
Location
VIC
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Collaborators
Hospital for Sick Kids, Toronto
Trial Status
Open
Sites
Monash Children's Hospital
Royal Children's Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
7 years to 17 years
ANZCTR
ACTRN12622000045718
Back to Registry
Study Title Phase III randomized double-blind placebo-controlled trial of metformin for cognitive recovery and white matter growth in paediatric medulloblastoma patients
Protocol ID MetMED
Disease (Sub Disease) Medulloblastoma
Diagnosis Stage Previously treated
Location VIC
Sponsor Australian and New Zealand Children's Haematology Oncology Group
Collaborators Hospital for Sick Kids, Toronto
Links https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381003&isReview=true
Trial Status Open
Trial Open Date 28/09/2022
Sites Monash Children's Hospital/ Royal Children's Hospital
Study Type Treatment
Phase Phase 3
Age Eligibility 7 years to 17 years
ANZCTR ACTRN12622000045718